Corbevax gets DCGI nod as heterologous COVID-19 booster dose
It is the first vaccine in India to get DCGI approval for a heterologous COVID-19 booster shot
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus Lifesciences receives final approval from US FDA for Famotidine tablets
Famotidine is a histamine H2 receptor blocker
Myovant Sciences and Pfizer announce US FDA acceptance of supplemental NDA for Myfembree
The US FDA set a target action date of 29th January, 2023 for this sNDA under the Prescription Drug User Fee Act (PDUFA)
Novartis partners with American Society of Hematology to fight Sickle Cell Disease in Sub-Saharan…
Six African nations will join a partnership pioneered in Ghana using technology to track and better tackle Sickle Cell Disease…
Entod Pharma gets DCGI nod to carry out phase-III trial of Atropine eye drops
Subject to a successful demonstration of safety and efficacy in clinical studies, Entod Pharma would be the first company to…
Immune modulator drugs improves survival for people hospitalised with COVID-19
NIH launched the ACTIV-1 immune modulators clinical trial to determine if certain drugs that help minimise the effects of an…
Researchers devise age-based eligibility method to measure vaccine effectiveness in data-deficient…
The team exploits the fact that many governments applied age-based eligibility cut-offs when rolling out their vaccination…
Boehringer Ingelheim enters global licensing agreement to develop and commercialise antibodies from…
This partnership allows Boehringer Ingelheim to strengthen its tumour cell-directed Antibody-Drug Conjugate (ADC) and immune…
Japan study shows women more likely to get skin rash from Moderna shot
The study of 5,893 participants between May and November last year showed that 22.4 per cent of women developed delayed skin…
FDA withdraws approval for TG Therapeutics cancer treatment
The withdrawal has been due to concerns of higher risk of death in patients receiving the drug